TY - JOUR T1 - The paradox of NKp46<sup>+</sup> natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment JF - Gut JO - Gut SP - 515 LP - 524 DO - 10.1136/gutjnl-2013-304472 VL - 63 IS - 3 AU - Tom Pembroke AU - Adam Christian AU - Emma Jones AU - Robert K Hills AU - Eddie C Y Wang AU - Awen M Gallimore AU - Andrew Godkin Y1 - 2014/03/01 UR - http://gut.bmj.com/content/63/3/515.abstract N2 - Objective There is evidence that natural killer (NK) cells help control persistent viral infections including hepatitis C virus (HCV). The phenotype and function of blood and intrahepatic NK cells, in steady state and after interferon (IFN) α treatment has not been fully elucidated. Design We performed a comparison of NK cells derived from blood and intrahepatic compartments in multiple paired samples from patients with a variety of chronic liver diseases. Furthermore, we obtained serial paired samples from an average of five time points in HCV patients treated with IFNα. Results Liver NK cells demonstrate a distinct activated phenotype compared to blood manifested as downregulation of the NK cell activation receptors CD16, NKG2D, and NKp30; with increased spontaneous degranulation and IFN production. In contrast, NKp46 expression was not downregulated. Indeed, NKp46-rich NK populations were the most activated, correlating closely with the severity of liver inflammation. Following initiation of IFNα treatment there was a significant increase in the proportion of intrahepatic NK cells at days 1 and 3. NKp46-rich NK populations demonstrated no reserve activation capacity with IFNα treatment and were associated with poor viral control on treatment and treatment failure. Conclusions NKp46 marks out pathologically activated NK cells, which may result from a loss of homeostatic control of activating receptor expression in HCV. Paradoxically these pathological NK cells do not appear to be involved in viral control in IFNα-treated individuals and, indeed, predict slower rates of viral clearance. ER -